The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group
Abstract
OBJECTIVE: The aim of this study was to investigate in a retrospective setting the patients' profile and results of those undergoing surgery for hepatocellular carcinoma (HCC) in high-volume surgical centers throughout the world. BACKGROUND: Whether surgery for HCC is a suitable approach and for which subset of patients is still controversial. The EASL/AASLD (European Association for the Study of Liver Disease/American Association for the Study of Liver Disease) guidelines, based on the Barcelona Clinic Liver Cancer (BCLC) classification, leave little room for hepatic resection; inversely, other reports promote its wider application. METHODS: On the basis of the network "Hepatocellular Carcinoma: Eastern & Western Experiences," data for 2046 consecutive patients resected for HCC in 10 centers were collected. According to the BCLC classification, 1012 (50%) were BCLC 0-A, 737 (36%) BCLC B, and 297 (14%) BCLC C. Analysis of overall survival and disease-free survival and multivariate analysis of prognostic factors were performed. FINDINGS: The 90-day mortality rate was 2.7%. Overall morbidity was 42%. After a median follow-up of 25 months (range, 1-209 months), the 1-, 3-, and 5-year overall survival rates were 95%, 80%, and 61% for BCLC 0-A; 88%, 71%, and 57% for BCLC B; and 76%, 49%, and 38% for BCLC C (P = 0.000). The 1-, 3-, and 5-year disease-free survival rates were as follows: 77%, 41%, and 21% for BCLC 0-A; 63%, 38%, and 27% for BCLC B; and 46%, 28%, and 18% for BCLC C (P = 0.000). The multivariate analysis identified bilirubin, cirrhosis, esophageal varices, tumor size, and macrovascular invasion to be statistical and independent prognostic factors for overall survival. CONCLUSIONS: This large multicentric survey shows that surgery is in current practice widely applied among patients with multinodular, large, and macrovascular invasive HCC, providing acceptable short- and long-term results and justifying an update of the EASL/AASLD therapeutic guidelines in this sense.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378 · cited 1×
“000 Sex [n = 2046] Men 757 (75) 586 (80) 228 (77) Women 255 (25) 151 (20) 69 (23) 0.”
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Estimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
Mazzaferro, V., Llovet, J. M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Camerini, T., Roayaie, S., Schwartz, M. E., Grazi, G. L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70284-5 · Cited by 2,045
Self-citationBruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J., Visa, J., Bru, C., & Rodes, J. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70070-7 · Cited by 895
Cammà, C., Schepis, F., Orlando, A., Albanese, M., Shahied, L., Trevisani, F., Andreone, P., Craxì, A., & Cottone, M. (2002) · Radiology · doi:10.1148/radiol.2241011262 · Cited by 851
One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years
Imamura, H. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.11.1198 · Cited by 835
Marelli, L., Stigliano, R., Triantos, C., Senzolo, M., Cholongitas, E., Davies, N., Tibballs, J., Meyer, T., Patch, D. W., & Burroughs, A. K. (2007) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-006-0062-3 · Cited by 791
Ishizawa, T., Hasegawa, K., Aoki, T., Takahashi, M., Inoue, Y., Sano, K., Imamura, H., Sugawara, Y., Kokudo, N., & Makuuchi, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.091 · Cited by 754
Self-citationHepatectomy for Hepatocellular Carcinoma: Toward Zero Hospital Deaths
Fan, S.-T., Lo, C.-M., Liu, C.-L., Lam, C.-M., Yuen, W.-K., Yeung, C., & Wong, J. (1999) · Annals of Surgery · doi:10.1097/00000658-199903000-00004 · Cited by 728
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort†
Marrero, J. A., Fontana, R. J., Barrat, A., Askari, F., Conjeevaram, H. S., Su, G. L., & Lok, A. S. (2005) · Hepatology · doi:10.1002/hep.20636 · Cited by 637
Hepatocellular Carcinoma: An Epidemiologic View
El-Serag, H. B. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200211002-00002 · Cited by 633
Torzilli, G. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.9.984 · Cited by 455
Self-citationProspective validation of the Barcelona Clinic Liver Cancer staging system
Cillo, U., Vitale, A., Grigoletto, F., Farinati, F., Brolese, A., Zanus, G., Neri, D., Boccagni, P., Srsen, N., D'Amico, F., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.015 · Cited by 425
Predictive Indices of Morbidity and Mortality After Liver Resection
Schroeder, R. A., Marroquin, C. E., Bute, B. P., Khuri, S., Henderson, W. G., & Kuo, P. C. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201483.95911.08 · Cited by 338
The General rules for recording endoscopic findings on esophageal varices
Japanese Research Society for Portal Hypertension, & Inokuchi, K. (1980) · The Japanese Journal of Surgery · doi:10.1007/bf02468653 · Cited by 319
Major achievements in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60381-0 · Cited by 283
Is Portal Hypertension a Contraindication to Hepatic Resection?
Cucchetti, A., Ercolani, G., Vivarelli, M., Cescon, M., Ravaioli, M., Ramacciato, G., Grazi, G. L., & Pinna, A. D. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b977a5 · Cited by 244
Ng, K. K., Vauthey, J.-N., Pawlik, T. M., Lauwers, G. Y., Regimbeau, J.-M., Belghiti, J., Ikai, I., Yamaoka, Y., Curley, S. A., Nagorney, D. M., et al. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.06.004 · Cited by 241
Self-citationPawlik, T. M. (2005) · Archives of Surgery · doi:10.1001/archsurg.140.5.450 · Cited by 224
Wang, J.-H., Changchien, C.-S., Hu, T.-H., Lee, C.-M., Kee, K.-M., Lin, C.-Y., Chen, C.-L., Chen, T.-Y., Huang, Y.-J., & Lu, S.-N. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.018 · Cited by 195
Bilimoria, M. M. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.5.528 · Cited by 195
Portal Hypertension: Contraindication to Liver Surgery?
Capussotti, L., Ferrero, A., Viganò, L., Muratore, A., Polastri, R., & Bouzari, H. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0524-9 · Cited by 156
Self-citationTorzilli, G., Donadon, M., Marconi, M., Palmisano, A., Fabbro, D. D., Spinelli, A., Botea, F., & Montorsi, M. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.11.1082 · Cited by 144
Self-citationPrognostic Prediction in Patients with Hepatocellular Carcinoma
Sala, M., Forner, A., Varela, M., & Bruix, J. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871197 · Cited by 87
Systematic Extended Right Posterior Sectionectomy
Torzilli, G., Donadon, M., Marconi, M., Botea, F., Palmisano, A., Fabbro, D. D., Procopio, F., & Montorsi, M. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31816387d7 · Cited by 80
Self-citationLiver resection for HCC with cirrhosis: Surgical perspectives out of EASL/AASLD guidelines
Capussotti, L., Ferrero, A., Viganò, L., Polastri, R., & Tabone, M. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.06.005 · Cited by 64
Self-citationScreening for hepatocellular carcinoma
Sherman, M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.11.006 · Cited by 49
Treatment of Stage IVA Hepatocellular Carcinoma
Chirica, M. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.6.538 · Cited by 36
Comparison of staging systems to predict survival in hepatocellular carcinoma
Pascual, S., Zapater, P., Such, J. M., García‐Herola, A., Sempere, L., Irurzun, J., Palazón, J. M., Carnicer, F., & Pérez‐Mateo, M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01282.x · Cited by 28
Screening for hepatocellular carcinoma.
Singal, A. S., & Marrero, J. A. (2008) · PubMed Central · Cited by 26
Is it time to reconsider the BCLC/AASLD therapeutic flow‐chart?
Livraghi, T., Brambilla, G., Carnaghi, C., Tommasini, M., & Torzilli, G. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21733 · Cited by 26
Self-citation
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Self-citationEvidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., et al. (2020) · Liver Cancer · doi:10.1159/000509424 · Cited by 800
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Zhou, J., Sun, H.-C., Wang, Z., Cong, W.-M., Wang, J.-H., Zeng, M.-S., Yang, J.-M., Bie, P., Liu, L.-X., Wen, T.-F., et al. (2018) · Liver Cancer · doi:10.1159/000488035 · Cited by 649
Metadata
- Authors
- Torzilli, G., Belghiti, J., Kokudo, N., Takayama, T., Capussotti, L., Nuzzo, G., Vauthey, J.-N., Choti, M. A., De Santibanes, E., Donadon, M., Morenghi, E., & Makuuchi, M.
- Venue
- Annals of Surgery
- Published
- 2013-05
- Volume
- 257
- Issue
- 5
- Pages
- 929-937
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2321984805
- Cited by
- 496
- References
- 40
- FWCI
- 23.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.